Stanford Builds Human Cell Foundation Model Integrating Multimodal Data to Accelerate Drug Discovery
A Stanford team is developing a human-centered foundation model to simulate human cells for accelerating drug discovery and personalized treatment. The project aims to integrate multimodal biological data—including sequences, structures, and literature—to provide generative tools comparable to AlphaFold for cell biologists worldwide.
Related Entities
Full Report
Scientists have dreamed of modeling the human cell ever since Robert Hooke discovered the fundamental unit of life in 1665. With AI’s ability to learn from vast amounts of biological data, the goal may be within reach.
A team at Stanford is collaborating to build a human-centered foundation model that can simulate human cells to accelerate drug discovery and personalized treatment for disease.
“We are not the first generation to think about modeling cells, but with AI, the opportunities are completely new,” says Emma Lundberg, associate professor of bioengineering and of pathology at Stanford.
Imagine testing experimental drugs on a digital twin of one’s cells before taking a prescription. A patient could understand the drug’s efficacies and side effects before swallowing a single pill. It’s a bold vision that comes with a host of technical challenges.
To successfully build a virtual cell, the team must overcome several challenges. First, the model needs to recognize different types of biological data, including DNA/RNA/protein sequences, protein structures, cellular images, and scientific literature. It also needs to understand different biological units and how they connect across scales, from molecules to cells to tissues, organs, and whole organisms.
Second, the virtual cell model needs a chat interface for biologists to interact with the data and upload their own datasets for analysis. To meet this need, the team developed Biomni (see below).
The hurdles are steep, but if they succeed, the team will create a valuable new tool for the field. “Generative models are incredible equalizers when it comes to lowering the cost of experiments. “For example, AlphaFold [the open-source AI system from Google DeepMind that predicts a protein’s 3D shape from its amino acid sequence] has democratized access to structural biology in recent years. With our virtual cell foundation model, we hope to make more such generative tools available to every cell biologist around the world,” Lundberg says.